Table 1.
Retention time (min) | Measured m/z | mSigma | Molecular formula | Metfrag IntCov (%) | Name | Mode | Fold change BW312/Bowman | p-value |
---|---|---|---|---|---|---|---|---|
Putatively identified | ||||||||
11.4 | 559.5199 | 2.64 | C36H66N2O2 | − | 2,5-Dimethyl-3,6-bis(tetradecylamino)-1,4-benzoquinone | + | −3.620 | 0.004041 |
10.6 | 200.20149 | 6.96 | C12H25NO | 5.94 | Dodecanamide | + | −2.856 | 0.006011 |
9.45 | 115.11185 | 2.71 | C7H14O | 25.053 | 2-Heptanone or 4-heptanone | + | −2.847 | 0.003034 |
10.17 | 221.11739 | 10.75 | C13H16O3 | 55.226 | (+)-(8R,8′R)-4-hydroxy-5-methoxy-1′,2′,3′,4′,5′,6′-hexanor-2,7′-cyclolignan-7′-one | + | −2.286 | 0.002676 |
10.18 | 203.10677 | 7.85 | C13H14O2 | 68.564 | Tremetone | + | −2.207 | 0.003948 |
8.65 | 421.2071 | 12.87 | C21H4OS4 | − | 1-[(2-Methyl-2-propanyl)sulfanyl]-1-{tris[(2-methyl-2-propanyl)sulfanyl]vinyl}cyclopropane | + | −2.186 | 0.003948 |
6.12 | 102.09145 | 2.99 | C5H11NO | − | Pentanamide | + | 2.094 | 0.010128 |
1.59 | 97.02845 | 3.30 | C5H4O2 | − | Furfural | + | 2.139 | 0.006011 |
9.13 | 244.19131 | 0.46 | C13H25NO3 | − | N-undecanoylglycine | + | 2.391 | 0.006011 |
11.95 | 532.21237 | 12.59 | C32H29N5OS | − | 2-{4-[(4-Methyl-1-piperazinyl)methyl]phenyl}-7-[(4-phenoxyphenyl)amino]thieno[3,2-b]pyridine-6-carbonitrile | + | 2.963 | 0.002700 |
0.92 | 171.01681 | 12.2 | C4H10O3S2 | − | 7H-adenine;2-amino-3,7-dihydropurin-6-one | + | 3.861 | 0.001745 |
Identified | ||||||||
7.80 | 189.11259 | 7.80 | C9H16O4 | − | Azelaic acid | + | 2.471 | 0.002676 |
Differential metabolites were determined using a Wilcoxon rank sum test with a p-value maximum set at 0.05. A molecular formula was generated for each metabolite of interest, with a maximum mSigma value of 20. When MS/MS was available, the putative identification was chosen using Metfrag in silico fragmentation. When MS/MS was not available, the putative identification was obtained by interrogation of libraries via Compound Crawler.